EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Simultaneous Dual-Gene Detection of Escherichia coli O157:H7 Based on a CRISPR/Cas13-Mediated Biosensor

Yawen He iD, Xiaodong Lin iD, Xuemei Zhang, Qiaoqiao Ci, Juhong Chen iD

JACS Au · 22.06.2026 · 6 (6) · 3473-3481

DOI: 10.1021/jacsau.6c00465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACS Au, online erschienen am 28.05.2026. Verfasst von Yawen He und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Systems Engineering, Virginia Tech, Blacksburg, Virginia 24061, United States. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High Resolution Image Download MS PowerPoint Slide Escherichia coli ( E. coli ) O157:H7 is a major foodborne pathogen that poses significant public health risks, requiring rapid and accurate detection methods. In this study, we developed a one-pot CRISPR/Cas13-based biosensor for the simultaneous detection of two key genetic markers: rfb E O157 and fli C H7 . By leveraging the distinct collateral cleavage preferences of LwaCas13a and PsmCas13b, the biosensor establishes dual fluorescence channels (TEX and FAM), enabling serotype-specific detection while minimizing false positives. The entire detection process (target gene amplification, transcription, and CRISPR-mediated biosensing) was integrated into a single reaction tube, eliminating the need for complex equipment and reducing the risk of contamination. The biosensor demonstrated high sensitivity, achieving a detection limit of 54 CFU/mL by using recombinase polymerase amplification (RPA). To validate its real-world applicability, an E. coli O157:H7 infection model was established in mice, and fecal samples were analyzed, showing results consistent with the standard PCR method. Compared with conventional CRISPR-based diagnostics, this approach enhances serotype discrimination, improves specificity, and offers a simple, rapid, and field-deployable solution for pathogen detection. Overall, this dual-channel biosensor provides a promising tool for clinical diagnostics, food safety monitoring, and infectious-disease surveillance.

Schlagwörter

Stichwörter der Autor:innen

CRISPR/Cas13E. colidisease detectiondual-channel biosensorone-pot

Autor:innen und Institutionen

  • Department of Biological Systems Engineering, Virginia Tech, Blacksburg, Virginia 24061, United States.
  • Department of Bioengineering, University of California, Riverside, California 92521, United States.
  • Center for Biostatistics and Health Data Science, Virginia Tech, Roanoke, Virginia 24016, United States.

ORCID-Profile: Yawen He, Xiaodong Lin, Juhong Chen

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

He, Y., Lin, X., Zhang, X., Ci, Q., & Chen, J. (2026). Simultaneous Dual-Gene Detection of Escherichia coli O157:H7 Based on a CRISPR/Cas13-Mediated Biosensor. JACS Au, 6(6), 3473-3481. https://doi.org/10.1021/jacsau.6c00465

Vancouver

He Y, Lin X, Zhang X, Ci Q, Chen J. Simultaneous Dual-Gene Detection of Escherichia coli O157:H7 Based on a CRISPR/Cas13-Mediated Biosensor. JACS Au. 2026;6(6):3473-3481. doi:10.1021/jacsau.6c00465

BibTeX
@article{He2026,
  author = {He, Yawen and Lin, Xiaodong and Zhang, Xuemei and Ci, Qiaoqiao and Chen, Juhong},
  title = {Simultaneous Dual-Gene Detection of Escherichia coli O157:H7 Based on a CRISPR/Cas13-Mediated Biosensor},
  journal = {JACS Au},
  year = {2026},
  volume = {6},
  number = {6},
  pages = {3473--3481},
  doi = {10.1021/jacsau.6c00465}
}
Kostenlos starten →